These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8179476)

  • 21. Synthesis and evaluation of pyrazolignans. A new class of cytotoxic agents.
    Gordaliza M; del Corral JM; Castro MA; López-Vázquez ML; San Feliciano A; García-Grávalos MD; Carpy A
    Bioorg Med Chem; 1995 Sep; 3(9):1203-10. PubMed ID: 8564411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells.
    Guo YE; Chen H; Zuo S; Liu DL; Lu YL; Lv JJ; Wen SP; Zhang TC
    J Asian Nat Prod Res; 2011 May; 13(5):417-24. PubMed ID: 21534039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioactive constituents from roots of Bursera tonkinensis.
    Jutiviboonsuk A; Zhang H; Tan GT; Ma C; Van Hung N; Manh Cuong N; Bunyapraphatsara N; Soejarto DD; Fong HH
    Phytochemistry; 2005 Dec; 66(23):2745-51. PubMed ID: 16289147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010).
    Lv M; Xu H
    Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and cytotoxicity of racemic isodeoxypodophyllotoxin analogues with isoprene-derived side chains.
    Zhao Y; Feng JH; Ding HX; Xiong Y; Cheng CH; Hao XJ; Zhang YM; Pan YJ; Guéritte F; Wu XM; Bai H; Stöckigt J
    J Nat Prod; 2006 Aug; 69(8):1145-52. PubMed ID: 16933865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 4beta-amido and 4beta-sulphonamido analogues of podophyllotoxin as potential antitumour agents.
    Kamal A; Ashwini Kumar B; Arifuddin M; Dastidar SG
    Bioorg Med Chem; 2003 Nov; 11(23):5135-42. PubMed ID: 14604676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on lignan lactone antitumor agents. I. Synthesis of aminoglycosidic lignan variants related to podophyllotoxin.
    Saito H; Yoshikawa H; Nishimura Y; Kondo S; Takeuchi T; Umezawa H
    Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3733-40. PubMed ID: 3815595
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemi-synthesis and biological activity of new analogues of podophyllotoxin.
    Roulland E; Magiatis P; Arimondo P; Bertounesque E; Monneret C
    Bioorg Med Chem; 2002 Nov; 10(11):3463-71. PubMed ID: 12213460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and cytotoxicity of podophyllotoxin analogues modified in the A ring.
    Castro A; del Corral JM; Gordaliza M; Grande C; Gómez-Zurita A; García-Grávalos D; San Feliciano A
    Eur J Med Chem; 2003 Jan; 38(1):65-74. PubMed ID: 12593917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of new selective cytotoxic cyclolignans derived from podophyllotoxin.
    Castro MA; Miguel del Corral JM; Gordaliza M; García PA; Gómez-Zurita MA; García-Grávalos MD; de la Iglesia-Vicente J; Gajate C; An F; Mollinedo F; San Feliciano A
    J Med Chem; 2004 Feb; 47(5):1214-22. PubMed ID: 14971901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activity of bromolignans and cyclolignans.
    San Feliciano A; Medarde M; Pelaez Lamamie de Clairac R; López JL; Puebla P; García Gravalos MD; Ruiz Lázaro P; García de Quesada MT
    Arch Pharm (Weinheim); 1993 Jul; 326(7):421-6. PubMed ID: 8395168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
    Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug delivery of anticancer agents: water soluble 4-poly (ethylene glycol) derivatives of the lignan, podophyllotoxin.
    Greenwald RB; Conover CD; Pendri A; Choe YH; Martinez A; Wu D; Guan S; Yao Z; Shum KL
    J Control Release; 1999 Sep; 61(3):281-94. PubMed ID: 10477801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on lignan lactone antitumor agents. II. Synthesis of N-alkylamino- and 2,6-dideoxy-2-aminoglycoside lignan variants related to podophyllotoxin.
    Saito H; Yoshikawa H; Nishimura Y; Kondo S; Takeuchi T; Umezawa H
    Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3741-6. PubMed ID: 3815596
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolation, purification, and cytotoxicity of 5-methoxypodophyllotoxin, a lignan from a root culture of Linum flavum.
    Van Uden W; Homan B; Woerdenbag HJ; Pras N; Malingré TM; Wichers HJ; Harkes M
    J Nat Prod; 1992 Jan; 55(1):102-10. PubMed ID: 1602298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
    Yang L; Liu YQ; Tan H; Li WG; Tian X
    Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in the Chemistry and Biology of Podophyllotoxins.
    Yu X; Che Z; Xu H
    Chemistry; 2017 Apr; 23(19):4467-4526. PubMed ID: 27726183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
    Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH
    Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents.
    Subrahmanyam D; Renuka B; Rao CV; Sagar PS; Deevi DS; Babu JM; Vyas K
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1391-6. PubMed ID: 9871772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of new C5-(1-substituted-1,2,3-triazol-4 or 5-yl)-2'-deoxyuridines and their antiviral evaluation.
    Montagu A; Roy V; Balzarini J; Snoeck R; Andrei G; Agrofoglio LA
    Eur J Med Chem; 2011 Feb; 46(2):778-86. PubMed ID: 21232828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.